CLINICAL_TRIALS
trial_result
· 2021-02-21
Clinical Trial Update: A Study of INO-3112 DNA Vaccine With Electroporation in Participants With Cervical Cancer [Phase 1, Phase 2]
Summary
Phase 1/2 study of INO-3112 DNA vaccine with electroporation in cervical cancer completed; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Inovio Pharmaceuticals | Conditions: Cervical Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-02-21